ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,377Medicare Part D Prescriptions Filled, Including Refills

Rank: 42 out of 298

$360K Total Retail Price of All Prescriptions

Rank: 72 out of 298

395 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 395 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 395 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 7,508 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LEVOTHYROXINE SODIUM 543 405 1 1
SIMVASTATIN 309 294 2 2
HYDROCODONE-ACETAMINOPHEN 277 215 S3 3 8
FUROSEMIDE 273 247 4 5
AMLODIPINE BESYLATE 268 250 5 6
OMEPRAZOLE 257 170 6 3
LISINOPRIL 253 218 7 4
WARFARIN SODIUM 191 177 8 7
LOSARTAN POTASSIUM 184 167 9 18
METFORMIN HCL 175 123 10 10
ALENDRONATE SODIUM 170 131 11 21
ATENOLOL 163 162 12 16
CITALOPRAM HBR 161 136 13 17
TAMSULOSIN HCL 155 118 14 24
METOPROLOL TARTRATE 139 116 15 9
SPIRONOLACTONE 129 99 16 34
DONEPEZIL HCL 127 114 17 22
METOPROLOL SUCCINATE 125 123 18 12
CARVEDILOL 124 115 19 23
ATORVASTATIN CALCIUM 122 100 20 14
CIPROFLOXACIN HCL 113 102 21 56
POTASSIUM CHLORIDE 105 105 22 11
TRAZODONE HCL 95 69 23 39
GABAPENTIN 94 77 24 20
DIGOXIN 84 84 25 27
CLOPIDOGREL 83 78 26 36
DIVALPROEX SODIUM 83 26 26 91
CARBAMAZEPINE 80 22 28 105
POLYETHYLENE GLYCOL 3350 79 61 29 29
FENTANYL 78 75 S2 30 32
GLIPIZIDE XL 75 63 31 92
ALLOPURINOL 70 48 32 28
LOVAZA 69 0 33 188
LOVASTATIN 67 67 34 64
TRAMADOL HCL 67 61 34 15
ZOLPIDEM TARTRATE 66 60 36 25
AZITHROMYCIN 63 48 37 63
FINASTERIDE 63 53 37 66
TOPIRAMATE 60 38 39 145
TRIAMTERENE-HCTZ 59 59 40 43
NAMENDA 57 44 41 35
DIOVAN 57 57 41 47
LACTULOSE 56 34 43 120
JANUVIA 56 23 43 73
SERTRALINE HCL 53 53 45 19
VERAPAMIL ER 51 47 46 88
LANTUS 50 50 47 53
PROMETHAZINE HCL 50 0 R 47 245
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.